The average one-year price target for Beta Bionics (NASDAQGM:BBNX) has been revised to $23.75 / share. This is an increase of 14.64% from the prior estimate of $20.72 dated September 11, 2026. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results